Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s41828
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Informa UK Limited